Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Fucoidan Prolongs the Circulation Time of Dextran-Coated Iron Oxide Nanoparticles.

Abdollah MRA, Carter TJ, Jones C, Kalber TL, Rajkumar V, Tolner B, Gruettner C, Zaw-Thin M, Baguña Torres J, Ellis M, Robson M, Pedley RB, Mulholland P, T M de Rosales R, Chester KA.

ACS Nano. 2018 Feb 27;12(2):1156-1169. doi: 10.1021/acsnano.7b06734. Epub 2018 Jan 17.

PMID:
29341587
2.

Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.

Weitsman G, Mitchell NJ, Evans R, Cheung A, Kalber TL, Bofinger R, Fruhwirth GO, Keppler M, Wright ZVF, Barber PR, Gordon P, de Koning T, Wulaningsih W, Sander K, Vojnovic B, Ameer-Beg S, Lythgoe M, Arnold JN, Årstad E, Festy F, Hailes HC, Tabor AB, Ng T.

Oncogene. 2017 Jun 22;36(25):3618-3628. doi: 10.1038/onc.2016.522. Epub 2017 Feb 6.

3.

Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.

Kalber TL, Ordidge KL, Southern P, Loebinger MR, Kyrtatos PG, Pankhurst QA, Lythgoe MF, Janes SM.

Int J Nanomedicine. 2016 May 9;11:1973-83. doi: 10.2147/IJN.S94255. eCollection 2016.

4.

Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Castillo SD, Tzouanacou E, Zaw-Thin M, Berenjeno IM, Parker VE, Chivite I, Milà-Guasch M, Pearce W, Solomon I, Angulo-Urarte A, Figueiredo AM, Dewhurst RE, Knox RG, Clark GR, Scudamore CL, Badar A, Kalber TL, Foster J, Stuckey DJ, David AL, Phillips WA, Lythgoe MF, Wilson V, Semple RK, Sebire NJ, Kinsler VA, Graupera M, Vanhaesebroeck B.

Sci Transl Med. 2016 Mar 30;8(332):332ra43. doi: 10.1126/scitranslmed.aad9982.

PMID:
27030595
5.

Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles.

Connell JJ, Patrick PS, Yu Y, Lythgoe MF, Kalber TL.

Regen Med. 2015;10(6):757-72. doi: 10.2217/rme.15.36. Epub 2015 Sep 21. Review.

6.

Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission Tomography.

Sander K, Galante E, Gendron T, Yiannaki E, Patel N, Kalber TL, Badar A, Robson M, Johnson SP, Bauer F, Mairinger S, Stanek J, Wanek T, Kuntner C, Kottke T, Weizel L, Dickens D, Erlandsson K, Hutton BF, Lythgoe MF, Stark H, Langer O, Koepp M, Årstad E.

J Med Chem. 2015 Aug 13;58(15):6058-80. doi: 10.1021/acs.jmedchem.5b00652. Epub 2015 Jul 24.

PMID:
26161456
7.

Sulfonium salts as leaving groups for aromatic labelling of drug-like small molecules with fluorine-18.

Sander K, Gendron T, Yiannaki E, Cybulska K, Kalber TL, Lythgoe MF, Årstad E.

Sci Rep. 2015 Apr 21;5:9941. doi: 10.1038/srep09941.

8.

Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging.

Badar A, Kiru L, Kalber TL, Jathoul A, Straathof K, Årstad E, Lythgoe MF, Pule M.

EJNMMI Res. 2015 Mar 28;5:18. doi: 10.1186/s13550-015-0097-z. eCollection 2015.

9.

Gold-silica quantum rattles for multimodal imaging and therapy.

Hembury M, Chiappini C, Bertazzo S, Kalber TL, Drisko GL, Ogunlade O, Walker-Samuel S, Krishna KS, Jumeaux C, Beard P, Kumar CS, Porter AE, Lythgoe MF, Boissière C, Sanchez C, Stevens MM.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):1959-64. doi: 10.1073/pnas.1419622112. Epub 2015 Feb 4.

10.

Coupled cellular therapy and magnetic targeting for airway regeneration.

Ordidge KL, Gregori M, Kalber TL, Lythgoe MF, Janes SM, Giangreco A.

Biochem Soc Trans. 2014 Jun;42(3):657-61. doi: 10.1042/BST20140089.

PMID:
24849234
11.

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma.

Sage EK, Kolluri KK, McNulty K, Lourenco Sda S, Kalber TL, Ordidge KL, Davies D, Gary Lee YC, Giangreco A, Janes SM.

Thorax. 2014 Jul;69(7):638-47. doi: 10.1136/thoraxjnl-2013-204110. Epub 2014 Feb 24.

12.

Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.

Campbell-Washburn AE, Price AN, Ellmerich S, Simons JP, Al-Shawi R, Kalber TL, Ghatrora R, Hawkins PN, Moon JC, Ordidge RJ, Pepys MB, Lythgoe MF.

Amyloid. 2013 Jun;20(2):93-8. doi: 10.3109/13506129.2013.787984. Epub 2013 Apr 26.

PMID:
23621497
13.

Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastases.

Kalber TL, Campbell-Washburn AE, Siow BM, Sage E, Price AN, Ordidge KL, Walker-Samuel S, Janes SM, Lythgoe MF.

PLoS One. 2013;8(1):e54903. doi: 10.1371/journal.pone.0054903. Epub 2013 Jan 31.

14.

Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging.

Mitchell N, Kalber TL, Cooper MS, Sunassee K, Chalker SL, Shaw KP, Ordidge KL, Badar A, Janes SM, Blower PJ, Lythgoe MF, Hailes HC, Tabor AB.

Biomaterials. 2013 Jan;34(4):1179-92. doi: 10.1016/j.biomaterials.2012.09.070. Epub 2012 Nov 3.

15.

Imaging the paediatric lung: what does nanotechnology have to offer?

Ordidge KL, Duffy BA, Wells JA, Kalber TL, Janes SM, Lythgoe MF.

Paediatr Respir Rev. 2012 Jun;13(2):84-8. doi: 10.1016/j.prrv.2011.07.001. Epub 2011 Aug 4. Review.

16.

Synthesis and characterization of a theranostic vascular disrupting agent for in vivo MR imaging.

Kalber TL, Kamaly N, Higham SA, Pugh JA, Bunch J, McLeod CW, Miller AD, Bell JD.

Bioconjug Chem. 2011 May 18;22(5):879-86. doi: 10.1021/bc100329t. Epub 2011 Apr 7.

PMID:
21410265
17.

Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.

Kenny GD, Kamaly N, Kalber TL, Brody LP, Sahuri M, Shamsaei E, Miller AD, Bell JD.

J Control Release. 2011 Jan 20;149(2):111-6. doi: 10.1016/j.jconrel.2010.09.020. Epub 2010 Oct 1.

PMID:
20888381
18.

A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.

Kalber TL, Kamaly N, So PW, Pugh JA, Bunch J, McLeod CW, Jorgensen MR, Miller AD, Bell JD.

Mol Imaging Biol. 2011 Aug;13(4):653-62. doi: 10.1007/s11307-010-0400-3.

PMID:
20809208
19.

Imaging of gadolinium spatial distribution in tumor tissue by laser ablation inductively coupled plasma mass spectrometry.

Kamaly N, Pugh JA, Kalber TL, Bunch J, Miller AD, McLeod CW, Bell JD.

Mol Imaging Biol. 2010 Aug;12(4):361-6. doi: 10.1007/s11307-009-0282-4. Epub 2009 Nov 17.

PMID:
19921340
20.

Longitudinal in vivo susceptibility contrast MRI measurements of LS174T colorectal liver metastasis in nude mice.

Kalber TL, Waterton JC, Griffiths JR, Ryan AJ, Robinson SP.

J Magn Reson Imaging. 2008 Dec;28(6):1451-8. doi: 10.1002/jmri.21600.

PMID:
19025954
21.

Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.

Cullis ER, Kalber TL, Ashton SE, Cartwright JE, Griffiths JR, Ryan AJ, Robinson SP.

Microvasc Res. 2006 Mar;71(2):76-84. Epub 2006 Mar 10.

PMID:
16530791
22.
23.

Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Robinson SP, Kalber TL, Howe FA, McIntyre DJ, Griffiths JR, Blakey DC, Whittaker L, Ryan AJ, Waterton JC.

Neoplasia. 2005 May;7(5):466-74.

Supplemental Content

Loading ...
Support Center